loadpatents
Patent applications and USPTO patent grants for Ginsberg; Mark H..The latest application filed is for "treatment of cerebral cavernous malformations".
Patent | Date |
---|---|
Treatment of Cerebral Cavernous Malformations App 20190111111 - Ginsberg; Mark H. ;   et al. | 2019-04-18 |
Microfluidic system and method for using same Grant 8,372,358 - Groisman , et al. February 12, 2 | 2013-02-12 |
Microfluidic System And Method For Using Same App 20110044865 - Groisman; Alexander ;   et al. | 2011-02-24 |
Vitro methods for determining in vivo thrombotic events Grant 7,122,324 - Ginsberg , et al. October 17, 2 | 2006-10-17 |
In vitro methods for determining in vivo thrombotic events App 20050136482 - Ginsberg, Mark H. ;   et al. | 2005-06-23 |
In vitro methods for determining in vivo thrombotic events Grant 6,787,320 - Ginsberg , et al. September 7, 2 | 2004-09-07 |
Structural models for cytoplasmic domains of transmembrane receptors App 20030224453 - Ginsberg, Mark H. ;   et al. | 2003-12-04 |
Compositions and methods for modulating Syk function App 20030113828 - Ginsberg, Mark H. ;   et al. | 2003-06-19 |
Structural Models For Cytoplasmic Domains Of Transmembrane Receptors App 20020198360 - GINSBERG, MARK H. ;   et al. | 2002-12-26 |
In vitro methods for determining in vivo thrombotic events App 20020177173 - Ginsberg, Mark H. ;   et al. | 2002-11-28 |
Polypeptides for promoting cell attachment Grant 6,316,412 - Ginsberg , et al. November 13, 2 | 2001-11-13 |
Methods and cell lines for identification of regulators of integrin activation Grant 5,932,421 - Ginsberg , et al. August 3, 1 | 1999-08-03 |
Polypeptides for promoting cell attachment Grant 5,843,774 - Ginsberg , et al. December 1, 1 | 1998-12-01 |
Characterization of platelet aggregation disorders Grant 5,656,442 - Ginsberg * August 12, 1 | 1997-08-12 |
Methods for identifying inhibitors of integrin activation Grant 5,523,209 - Ginsberg , et al. June 4, 1 | 1996-06-04 |
Polypeptides for promoting cell attachment Grant 5,492,890 - Ginsberg , et al. February 20, 1 | 1996-02-20 |
Polypeptides that mimic receptor-induced binding sites, and methods of using same Grant 5,372,933 - Zamarron , et al. December 13, 1 | 1994-12-13 |
Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation Grant 5,306,620 - Ginsberg , et al. April 26, 1 | 1994-04-26 |
Antibodies that bind to a ligand-induced binding site on GPIIIa Grant 5,284,751 - Frelinger, III , et al. February 8, 1 | 1994-02-08 |
Peptides and antibodies that inhibit integrin-ligand binding Grant 5,262,520 - Plow , et al. * November 16, 1 | 1993-11-16 |
Peptides and antibodies that inhibit integrin-ligand binding Grant 5,204,445 - Plow , et al. * April 20, 1 | 1993-04-20 |
Characterization of platelet aggregation disorders Grant 5,196,309 - Ginsberg March 23, 1 | 1993-03-23 |
Peptides and antibodies that inhibit integrin-ligand binding Grant 5,196,511 - Plow , et al. March 23, 1 | 1993-03-23 |
Methods and compositions for diagnosing chronic immune thrombocytopenic purpura Grant 5,177,188 - Ginsberg , et al. January 5, 1 | 1993-01-05 |
Peptides and antibodies that inhibit integrin-ligand binding Grant 5,149,780 - Plow , et al. September 22, 1 | 1992-09-22 |
Peptides and antibodies that inhibit platelet adhesion Grant 5,114,842 - Plow , et al. May 19, 1 | 1992-05-19 |
Detection of activated platelets with antibodies to thrombospondin Grant 4,820,505 - Ginsberg , et al. April 11, 1 | 1989-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.